CClinicalTrials.gg
CompletedNCT05370378Updated Apr 6, 2023

Effects of Hold Relax With Agonist Contraction and Active Release Therapy on Clinical Outcomes in Piriformis Syndrome

An interventional study of Hold Relax with Agonist Contraction and Active Release Therapy in Piriformis Syndrome, sponsored by University of Lahore. Completed at 1 site in Pakistan. Open to participants aged 25 Years to 55 Years. Per ClinicalTrials.gov, last updated 2023-04-06.

Sponsored by University of Lahore · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
82
Allocation
Randomized
Ages
25 Years to 55 Years
Sex
All
01

Study summary

The aim of this study is to compare the effects of hold relax agonist contraction and active release therapy on reducing pain intensity, improving functioning and sleep quality in patient with piriformis syndrome.

Both these techniques are passive, non-invasive manual therapy techniques which are easy to perform and less time consuming and may yield better outcomes resulting improved quality of life.

02

Conditions studied

  • Piriformis Syndrome

Keywords

  • Function, Pain,Hold Relax ,Sleep Quality, Mobilization
03

In context

Piriformis Muscle Syndrome

53 studies on the registry are indexed under Piriformis Muscle Syndrome; 22 are open to participants now.

This study's enrollment of 82 is above the median of 42 across 47 interventional studies indexed under Piriformis Muscle Syndrome.

Browse Piriformis Muscle Syndrome studies →

Lead sponsor

University of Lahore is the lead sponsor of 223 studies on the registry; 40 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
25 Years to 55 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. Age group 25-55 years
  2. Both male and female.
  3. Gluteal pain with or without radicular symptoms.
  4. Patients of piriformis syndrome diagnosed by orthopedic consultant.
  5. Sub-acute and chronic piriformis syndrome.
  6. Unilateral pain.
  7. Pain score equal to and greater than 3 according to pain rating scale.

Exclusion criteria

Exclusion Criteria:

  1. Intermittent vascular claudication and spondylolisthesis.
  2. Past history of hip, femur or vertebral fracture
  3. Past history of spinal surgery.
  4. Spinal tuberculosis.
  5. Rheumatoid disease.
  6. Disc pathology, sacroiliac joint dysfunction or mechanical back pain.
  7. History of infectious disease.
  8. Leg length discrepancy.
  9. Any postural abnormality or deformity.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
82 participants (actual)

Study arms

  • Experimental
    Group A

    This group of participants will receive Hold Relax with Agonist Contraction (HR-AC) technique with routine physical therapy. The protocol will be given to the participants for two weeks (6 sessions on alternate days, 3 session per week). Each session will be of 60 minutes. The data will be collected before applying intervention, at first week and at 2nd week.

    Other: Hold Relax with Agonist Contraction

  • Active comparator
    Group B

    This group of participants will receive Active Release Therapy, a kind of soft tissue mobilization along with routine physical therapy. The protocol will be given to the participants for two weeks (6 sessions on alternate days, 3 session per week). Each session will be of 60 minutes. The data will be collected before applying intervention, at first week and at 2nd week.

    Other: Active Release Therapy

Interventions

  • OtherHold Relax with Agonist Contraction

    1. Participant will be in prone lying and heating pad will be applied on gluteal region for 10 to 15 minutes. 2. Passive sustained stretch to piriformis will be applied for 10 seconds. 3. The participant will be asked to actively contract the muscle for about 10 seconds (isometric contraction) and then relax. 4. Immediately after that participant is ask to again actively contract the muscle against therapist resistance for 6-10 seconds. 5. Ask the participant to relax while therapist will apply stretch the muscle to its new tissue tension barrier position and this position will be maintained for 30 seconds. 6. This maneuver is repeated for 3 to 4 repetitions, each starting from where the previous finished.

    Also known as: Proprioceptive Neuromuscular Facilitation Technique

  • OtherActive Release Therapy

    1. Specific muscle will be warmed up by applying heating pad for 10 to 15 minutes. 2. Patient will be positioned prone lying and the therapist will be standing at the side of affected limb. 3. Therapist will apply deep pressure at the area of tenderness while patient will actively move the limb from internal to external rotation repeatedly. 4. This maneuver will take about 15 minutes to complete in one session and will be applied alternatively 3 days a week for two weeks. 5. After this, cold pack is applied and general ROMs and strengthening exercises are performed to prevent soreness

    Also known as: Soft Tissue Mobilization

06

What researchers measure

Primary outcomes

  1. Change in Pain Intensity

    Numeric Pain Rating Scale will be used to measure the intensity of pain

    Time frame: Pain score will be measured at the baseline, at end of first session and at 6th session on 2nd week

  2. Change in Functional Disability

    Ronald-Morris Disability Questionnaire will be used to a assess the level of disability

    Time frame: Change in functional status will be measured at the baseline, at end of first session and at end of 6th session

  3. Sleep Quality

    Chronic Pain Sleep Inventory will be used to to assess the quality of sleep on a 100 mm VAS scale

    Time frame: Sleep quality will be measured at the baseline, at end of first session and at end of 6th session

07

Study locations

1 site
  • The University of Lahore
    Lahore, Punjab 54000, Pakistan
08

References and documents

Individual participant data

Plan to share: Yes — Individual participant data that underlies the results reported in article after deidentification

Supporting information: Study protocol

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 6, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05370378
Lead sponsor
University of Lahore
Responsible party
Ayesha Jamil (Dr. Ayesha Jamil, University of Lahore) — Principal investigator
First posted
May 11, 2022
Start date
Feb 22, 2022
Primary completion
Nov 22, 2022
Completion
Nov 22, 2022
Last update
Apr 6, 2023

Study contacts

Ayesha Jamil, M.Phil
study chair · The University of Lahore

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion